Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 2
Sponsor: Yale University • ClinicalTrials.gov ID: NCT07796074
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Anesthetic greater occipital nerve (GON) blockade is a simple, inexpensive, and safe procedure that has demonstrable headache pain suppressing effects. In this study, Veterans with post-traumatic headache will be randomized to receive 0.0%, 0.05%, or 0.5% bupivacaine in bilateral GON blocks and the lasting (i.e., transitional) effects on headache frequency measured in a headache diary.
Interventions
-
Bupivacaine bilateral greater occipital nerve block
(Drug)
Three subcutaneous injections of 1 mL each will be injected on both sides of the occipital region around the greater occipital nerve.
Eligibility criteria
Conditions
Locations
- VA Connecticut Healthcare System — West Haven, Connecticut, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record